Qinlock Prices, Coupons, Copay Cards & Patient Assistance
Qinlock (ripretinib) is a member of the multikinase inhibitors drug class and is commonly used for Gastrointestinal Stromal Tumor.
The cost for Qinlock 50 mg oral tablet is around $46,415 for a supply of 90 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Qinlock is available as a brand name drug only, a generic version is not yet available. View generic Qinlock availability for more details.
Qinlock prices
Oral Tablet
50 mg
Qinlock oral tablet
from $46,415.09
for 90 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 90 | $515.72 | $46,415.09 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Qinlock Coupons, Copay Cards and Rebates
Qinlock offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Qinlock Commercial Copay Program
Eligible commercially insured patients may pay as as little as $0 per prescription.
- Applies to:
- Qinlock
- Number of uses:
- Per prescription until program expires
Form more information phone: 833-432-2237 or Visit website
Qinlock Rapid Start Program
Eligible commercially insured patients may be eligible for a FREE, temporary prescription while waiting for insurance coverage approval.
- Applies to:
- Qinlock
- Number of uses:
- Temporary Assistance
Form more information phone: 833-432-2237 or Visit website
Qinlock Bridge Program
Eligible commercially insured patients may be eligible for a FREE, temporary prescription if experiencing a lapse in insurance coverage.
- Applies to:
- Qinlock
- Number of uses:
- Temporary Assistance
Form more information phone: 833-432-2237 or Visit website
Patient Assistance & Copay Programs for Qinlock
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Qinlock (ripretinib) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: Deciphera AccessPoint: Qinlock
Eligibility requirements:- Must be uninsured or underinsured
- Based on FPL
- Medically Necessary as determined by a Doctor
- Must be residing in the US or US territory
- Co-payment assistance, reimbursement support, patient support, and patient assistance programs are available for eligible patients. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Qinlock (ripretinib) Tablet
More information please phone: 833-432-2237 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Stivarga
Stivarga (regorafenib) is used to treat metastatic colorectal cancer, gastrointestinal stromal ...
Tepezza
Tepezza (teprotumumab) infusion is used for thyroid eye disease (TED). Includes Tepezza side ...
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Sutent
Sutent is a cancer medicine that is used to treat certain types of advanced or progressive tumors ...
Imkeldi
Imkeldi is used to treat specific types of leukemia (blood cancer), bone marrow disorders ...
Avapritinib
Avapritinib systemic is used for gastrointestinal stromal tumor, systemic mastocytosis
Sunitinib
Sunitinib systemic is used for gastrointestinal stromal tumor, pancreatic cancer, renal cell carcinoma
Regorafenib
Regorafenib systemic is used for colorectal cancer, gastrointestinal stromal tumor, hepatocellular ...
More about Qinlock (ripretinib)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
